Profile
Michéle Roy is currently the Vice President-Corporate Communications at ID Biomedical Corp.
She previously worked as the Director-North American Corporate Communications at Shire Plc from 2001 to 2003, Director-Corporate Communications at Biochem Pharma, Inc., and Vice President-Communications & Public Affairs at RONA, Inc. Ms. Roy obtained an undergraduate degree from the University of Montréal.
Michéle Roy active positions
| Companies | Position | Start |
|---|---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Investor Relations Contact | - |
Former positions of Michéle Roy
| Companies | Position | End |
|---|---|---|
| SHIRE | Public Communications Contact | 31/12/2002 |
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products focused on infectious diseases and cancer | Public Communications Contact | - |
| RONA INC. | Public Communications Contact | - |
Training of Michéle Roy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Health Technology |
RONA, Inc.
RONA, Inc. Specialty StoresRetail Trade Retails home improvement products | Retail Trade |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products focused on infectious diseases and cancer | Health Technology |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Michéle Roy
















